Abstract
A nationwide study of aplastic anemia in Israel revealed a mean yearly incidence of 7.1/1,000,000 in males and 8.7/1,000,000 in females. Twenty-five per cent of the cases reported had an apparent chloramphenicol etiology. Ten patients, five treated with chloramphenicol and five without it, developed acute leukemia. The median survival was 11 months in males and 28 in females. Survival was particularly inferior in chloramphenicol-related cases, suggesting that this group constitutes a specific entity.
Citations
Jan 1, 1983·European Journal of Clinical Pharmacology
May 12, 2005·Lancet·Robert A Brodsky, Richard J Jones
Dec 9, 1994·International Journal of Health Care Quality Assurance·S Penchas, M Shani
Apr 1, 1992·Baillière's Clinical Haematology·E C Gordon-Smith, S Issaragrisil
Nov 25, 2003·British Journal of Haematology·K R MuirE C Gordon-Smith
Jan 1, 1986·Acta paediatrica Scandinavica·N Clausen
Jan 1, 1986·British Journal of Haematology·N S YoungF Takaku
Feb 20, 2004·Hematology·Herminia Benítez-ArandaHector Mayani
Dec 14, 2004·The Annals of Pharmacotherapy·Chin HurG Scott Gazelle
Nov 26, 2002·American Journal of Hematology·Eliane M C P MalufDavid W Kaufman
Jun 1, 1981·Cancer·L GordisJ A Tonascia
Jul 17, 2003·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Peter J Carey
Jul 9, 1999·American Journal of Hematology·S IssaragrisilN S Young
Jul 1, 1990·European Journal of Haematology·M Keisu, A Ost